Innovation and collaboration for microbiome therapeutics at Microbiome Connect
13 Aug 2023
Microbiome Connect is an event where a community of 300 scientists and entrepreneurs converge, sharing a common passion for the microbiome. The event's purpose is to unite individuals committed to delivering inventive products to patients. Experts from various perspectives collaborate to create a platform enabling the unlocking of the microbiome's complete therapeutic potential.
Amanda Burkardt, Chief Executive Officer at Phiogen is one of 65 trailblazing speakers at the upcoming Microbiome Connect: USA event in Boston, November 14-16. In this video, Burkardt discusses Phiogen's mission, the main benefits of phage therapy, emerging modalities in the microbiome world, and shares a sneak peek into what will be covered in their session at Microbiome Connect: USA.
For more information about this event and to register your space, click here.
About the company
Kisaco Research
Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.